AskBorsa

Nile Pharmaceuticals results, Q1 2027

Net profit, assets, equity and cash flow for Q1 2027, against the same period a year earlier, from the published financial statements. fiscal year starts in July. The figures cover the 3 months to 30 September 2026; the comparison is with the same months a year earlier, from the same disclosure.

Net profit74.07 millionEGP · −30.5% vs the same period a year earlier

In short

  • Nile Pharmaceuticals's net profit for Q1 2027 was about 74.07 million EGP, down −30.5% from 107 million EGP in Q1 2026.
Source: the company's Q1 2027 results disclosure to the Egyptian Exchange

Key lines against the same period a year earlier

This periodQ1 2026Change
Net profit74.07 million107 million−30.5%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. The figures cover the 3 months to 30 September 2026; the comparison is with the same months a year earlier, from the same disclosure.

Official disclosure (PDF)All of Nile Pharmaceuticals's statements, five yearsAsk the AI analyst about NIPH

Nile Pharmaceuticals's Q2 2027 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for Nile Pharmaceuticals